Literature DB >> 20403283

[Laparoscopic adrenalectomy. Five-year experience].

A Aguilera Bazán1, M Pérez Utrilla, C Alvarez Escolá, J Reinoso, A Fernández Martínez, J Cisneros Ledo, J de la Peña Barthel.   

Abstract

OBJECTIVE: Adrenal conditions requiring surgery are uncommon and are usually seen in several surgical departments. Our experience in laparoscopic management of adrenal pathology after almost five years of use of laparoscopy for retroperitoneal conditions at our center is reported.
MATERIALS AND METHODS: A total of 37 laparoscopic adrenalectomies were performed over 53 months for benign and malignant conditions. The transperitoneal approach was used in most cases (97%) because of the greater surgeon experience with this route. Pregnancy and suspected periadrenal infiltration were considered as absolute contraindications.
RESULTS: Mean operating time was 90 minutes, mean intraoperative bleeding 80 ml, and mean hospital stay was 2 days. The main complication was one death. A malignancy was found in 4 patients (10%), while all other patients (90%) had a benign condition, including 8 pheochromocytomas.
CONCLUSIONS: Laparoscopy is considered to be the gold standard for benign adrenal conditions. When the malignant mass is a single metastasis from a primary tumor, the laparoscopic approach appears to be reliable. When the malignant lesion is a primary adrenal tumor, laparoscopic management is more controversial, although the results reported by experienced surgeons in their series appear to be adequate.

Entities:  

Mesh:

Year:  2010        PMID: 20403283     DOI: 10.1016/s2173-5786(10)70037-8

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  1 in total

1.  Two-stage bilateral laparoscopic adrenalectomy for large pheochromocytomas.

Authors:  Virgilijus Beisa; Michail Klimovskij; Gintaras Simutis; Audrius Sileikis; Kęstutis Strupas
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-02-26       Impact factor: 1.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.